• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Andera Partners

EdRip closes fourth life sciences fund on €192m

Edmond de Rothschild Investment Partners (EdRip) has held the final close of its fourth life sciences fund, BioDiscovery 4, on €192m.

  • Venture
  • 04 November 2013
ICG refinances Exclusive Networks

Intermediate Capital Group (ICG) has provided a senior debt package to refinance Omnes Capital-backed Exclusive Networks.

  • France
  • 26 September 2013
EdRip's fourth life sciences fund nears target

Edmond de Rothschild Investment Partners (EdRip) has so far raised €192m for its fourth life sciences fund, BioDiscovery 4, meaning the vehicle is close to reaching its target.

  • France
  • 16 August 2013
Gimv et al. back Jenavalve

A consortium of venture capital investors has injected $62.5m as part of a series-C round for Jenavalve Technology, a Germany-based medical devices manufacturer.

  • DACH
  • 23 July 2013
EdRip backs DufyElec in SBO

Edmond de Rothschild Investment Partners (EdRip) has acquired a minority stake in DufyElec from the company’s private equity owner Naxicap Partners.

  • France
  • 12 July 2013
EdRip in CHF 18m OncoEthix series-B round

Edmond de Rothschild Investment Partners (EdRip) has participated in a series-B funding round totalling CHF 18m for Swiss oncology drug development firm OncoEthix.

  • DACH
  • 09 July 2013
EdRip injects €5m into Prozone-Amisco

Edmond de Rothschild Investment Partners (EdRip) has invested €5m in Prozone-Amisco, a French sports data business that is also backed by XAnge Private Equity and Midi Capital.

  • Expansion
  • 04 July 2013
Gimv and EdRip back Complix with €12m

Gimv and Edmond de Rothschild Investment Partners (EdRip) have led a €12m series-B round for Belgian biopharmaceutical company Complix.

  • Benelux
  • 26 June 2013
EdRip takes minority stake in MCI

Edmond de Rothschild Investment Partners (EdRip) has taken part in a capital increase for Swiss events organisation business MCI.

  • DACH
  • 30 May 2013
Wellington invests €4m in €18.2m Genticel series-C

Wellington Partners has injected €4m into French vaccine developer Genticel as part of an €18.2m series-C funding round alongside existing shareholders.

  • Early-stage
  • 24 April 2013
Ace Management in €4m round for Ocea

Ace Management has joined existing investor Edmond de Rothcshild Investment Partners (EdRip) in a €4m round for French aluminium boats manufacturer Ocea.

  • France
  • 11 April 2013
FSI et al. in €28m round for SuperSonic Imagine

A consortium of investors, led by the Fonds Stratégique d'Investissement (FSI) and comprising several European venture players, has provided ultrasound systems developer SuperSonic Imagine with a €28m round of funding.

  • France
  • 04 April 2013
EdRip and BNP Paribas to back RBI spinout

Edmond de Rothschild Investment Partners (EdRip) and BNP Paribas Développement have entered exclusive negotiations to back the management buyout of French media group Reed Business Information (RBI) from its parent company Reed Elsevier.

  • France
  • 13 March 2013
EdRip planning to raise extra €500m by 2017

French GP Edmond de Rothschild Investment Partners (EdRip) is planning to close its latest healthcare fund on €200m in 2013 and raise two new growth capital vehicles within the next four years.

  • France
  • 31 January 2013
EdRip et al. support Groupe Marietton OBO

Edmond de Rothschild Investment Partners (EdRip), Crédit Agricole Régions Investissement and Siparex have backed the secondary owner buyout of French travel specialist Groupe Marietton.

  • France
  • 17 January 2013
EdRIP invests in secondary OBO of Itesa

Edmond de Rothschild Investment Partners (EdRIP) has taken a minority stake in the owner buyout of French security equipment distributor Itesa, allowing existing backer MBO Partners to exit the business.

  • France
  • 15 January 2013
EdRIP leads €13m series B round in Poxel

Edmond de Rothschild Investment Partners (EdRIP) has led a €13m series-B round for French biopharma company Poxel.

  • France
  • 18 December 2012
EdRIP to make 10x on Vessix sale

Edmond de Rothschild Investment Partners (EdRIP) stands to reap a sizeable 10x return on its original investment in US-based Vessix Vascular, following the $425m sale of the business to trade player Boston Scientific Corp.

  • France
  • 08 November 2012
EdRIP and Iris back ProwebCE take-private

Edmond de Rothschild Investment Partners (EdRIP) and Iris Capital have backed the take-private of French support services business ProwebCE, alongside trade player Edenred.

  • France
  • 08 October 2012
EdRIP takes stake in Alouette OBO

Edmond de Rothschild Investment Partners (EdRIP) has taken a minority stake in the owner buyout of French radio station Alouette.

  • France
  • 18 September 2012
EdRIP backs Groupe DEFI spin-off

Edmond de Rothschild Investment Partners (EdRIP) has taken a minority stake in the management buyout of French advertisement technology specialist Groupe DEFI.

  • France
  • 07 September 2012
EdRIP et al. in CHF 25m GenKyoTex series-C extension

Edmond de Rothschild Investment Partners (EdRIP), Vesalius Biocapital Partners, Mitsubishi Pharma Corporate Venture and other investors have provided Swiss biopharma GenKyoTex with CHF 25m of early-stage funding.

  • DACH
  • 09 July 2012
EdRIP backs Edimark Santé OBO

Edmond de Rothschild Investment Partners (EdRIP) has taken a minority stake in the owner buyout of medcdtll, a newco regrouping French medical publishing companies Edimark Santé and Espace Information Dentaire.

  • France
  • 04 July 2012
PE-backed EOS Imaging in €120m IPO

French medical devices business EOS Imaging, a portfolio company of Edmond de Rothschild Investment Partners (EdRIP) and NBGI Ventures among other investors, has listed on NYSE Euronext.

  • France
  • 16 February 2012
6 7 8
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013